SCHEMBL13622271

SCHEMBL13622271

C/C=C/C(=O)N[C@H]1CCc2cc(OC)c(O)c(OC)c2-c2ccc(SC)c(=O)cc21

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 12/20 0.80
TUBB4A P04350 11/20 0.80
TUBB P07437 11/20 0.80
TUBA3C P0DPH7 11/20 0.80
TUBA1B P68363 11/20 0.80
TUBA4A P68366 11/20 0.80
TUBB4B P68371 11/20 0.80
TUBB3 Q13509 11/20 0.80
TUBB2A Q13885 11/20 0.80
TUBB8 Q3ZCM7 11/20 0.80
TUBA3E Q6PEY2 11/20 0.80
TUBA1A Q71U36 11/20 0.80
TUBA1C Q9BQE3 11/20 0.80
TUBB6 Q9BUF5 11/20 0.80
TUBB2B Q9BVA1 11/20 0.80
TOP2A P11388 1/20 0.68
TOP2B Q02880 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622267 0.93 TUBB1 (0.80) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622213 0.93 TUBB4A (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2146845 0.89 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622218 0.88 TUBB4A (0.75) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622281 0.88 TUBB4A (0.75) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622276 0.85 TUBB1 (0.62) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622207 0.85 TUBB1 (0.80) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13622272 0.84 TUBB1 (0.74) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12402700 0.83 TUBB1 (0.88) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13438483 0.82 TUBB4A (0.88) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021427-A1 Novel tricyclic derivatives and their use NFATC1, IL2, CCL2 TUBB1 14/4885TUBB4A 45/4885TUBB 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.